Tarsus Pharmaceuticals Inc header image

Tarsus Pharmaceuticals Inc

TARS

Equity

ISIN null / Valor 57410241

NASDAQ (2026-10-29)

USD 74.20+2.98%

Tarsus Pharmaceuticals Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Tarsus Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative treatments for diseases with significant unmet medical needs. The company has gained recognition for its FDA-approved product, XDEMVY® (lotilaner ophthalmic solution) 0.25%, which is the first treatment specifically approved for Demodex blepharitis, a condition affecting millions of patients. Tarsus is committed to expanding its pipeline with a focus on addressing large-scale diseases that currently have limited treatment options, thereby aiming to improve patient outcomes across various therapeutic areas.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

9.89%1Y

439%3Y

167%5Y

Performance

44.9%1Y

52.0%3Y

58.4%5Y

Volatility

3256 M

Market cap (USD)

458,416

Daily traded volume (Shares)

57.03 / 53.92

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

OEM International AB

OEM International AB Valor: 118721488

Annual Return

-50%0%+50%

Risk level

110

0.83%SEK 171.00

Pitney Bowes Inc.

Pitney Bowes Inc. Valor: 962890

Annual Return

-50%0%+50%

Risk level

110

-5.62%USD 16.46

QXO Inc

QXO Inc Valor: 135786409

Annual Return

-50%0%+50%

Risk level

110

4.79%USD 11.38

Veracyte Inc

Veracyte Inc Valor: 22423969

Annual Return

-50%0%+50%

Risk level

110

3.70%USD 52.17

Hewlett Packard Enterprise Co

Hewlett Packard Enterprise Co Valor: 29968909

Annual Return

-50%0%+50%

Risk level

110

-2.42%USD 58.87

LG Electronics Inc. Sponsored GDR Pfd 144A

LG Electronics Inc. Sponsored GDR Pfd 144A Valor: 1405127

Annual Return

-50%0%+50%

Risk level

110

-5.92%GBP 15.70

ProFrac Holding Corp

ProFrac Holding Corp Valor: 115040472

Annual Return

-50%0%+50%

Risk level

110

-2.81%USD 4.85

Uber Technologies Inc

Uber Technologies Inc Valor: 47459333

Annual Return

-50%0%+50%

Risk level

110

-0.73%USD 65.26

Bio-Techne Corp

Bio-Techne Corp Valor: 25995847

Annual Return

-50%0%+50%

Risk level

110

0.03%USD 72.71

United Therapeutics Corp

United Therapeutics Corp Valor: 848383

Annual Return

-50%0%+50%

Risk level

110

1.20%USD 593.54

SIX

FactSet

Clearbit

Logos provided by Clearbit